The Effect of Prophylactic TPO Combined with BMS-IMRT to Esophageal Cancer Patients

NCT05944809 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Cancer
Intensity-modulated Radiation Therapy
Concurrent Chemoradiotherapy
Thrombocytopenia

Interventions

DRUG: rhTPO

Sponsor

JIANYANG WANG

Collaborators

[object Object]